BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1864012)

  • 1. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro.
    Tai PC; Sun L; Spry CJ
    Clin Exp Immunol; 1991 Aug; 85(2):312-6. PubMed ID: 1864012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression.
    Gregory B; Kirchem A; Phipps S; Gevaert P; Pridgeon C; Rankin SM; Robinson DS
    J Immunol; 2003 Jun; 170(11):5359-66. PubMed ID: 12759409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.
    Tai PC; Spry CJ
    Clin Exp Immunol; 1990 Jun; 80(3):426-34. PubMed ID: 2197048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor.
    Levi-Schaffer F; Temkin V; Malamud V; Feld S; Zilberman Y
    J Immunol; 1998 Jun; 160(11):5554-62. PubMed ID: 9605160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction.
    Ohnishi T; Kita H; Weiler D; Sur S; Sedgwick JB; Calhoun WJ; Busse WW; Abrams JS; Gleich GJ
    Am Rev Respir Dis; 1993 Apr; 147(4):901-7. PubMed ID: 8466126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of cytokines and fibroblasts on eosinophilic granulocyte survival in polyposis nasi].
    Rudack C; Hauser U; Stoll W
    Laryngorhinootologie; 1999 Jul; 78(7):378-81. PubMed ID: 10457519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5.
    Sonoda Y; Arai N; Ogawa M
    Leukemia; 1989 Jan; 3(1):14-8. PubMed ID: 2642572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Humoral regulation of eosinophilopoiesis by interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-5].
    Sonoda Y
    Nihon Rinsho; 1993 Mar; 51(3):565-70. PubMed ID: 8492428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis.
    Alam R; Forsythe P; Stafford S; Fukuda Y
    J Exp Med; 1994 Mar; 179(3):1041-5. PubMed ID: 8113672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions.
    Nishinakamura R; Miyajima A; Mee PJ; Tybulewicz VL; Murray R
    Blood; 1996 Oct; 88(7):2458-64. PubMed ID: 8839836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed eosinophil apoptosis in asthma.
    Kankaanranta H; Lindsay MA; Giembycz MA; Zhang X; Moilanen E; Barnes PJ
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):77-83. PubMed ID: 10887309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of CD23, CD25 and CD4 expression on an eosinophilic cell line (EoL-3) by interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-5 (IL-5).
    Chihara J; Gruart V; Plumas J; Tavernier J; Kusnierz JP; Prin L; Capron A; Capron M
    Eur Cytokine Netw; 1992; 3(1):53-61. PubMed ID: 1533800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophil colony-stimulating factor induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy.
    Nakamura Y; Ozaki T; Yanagawa H; Yasuoka S; Ogura T
    Am J Respir Cell Mol Biol; 1990 Oct; 3(4):291-300. PubMed ID: 2206537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil viability-enhancing activity in sputum from patients with bronchial asthma, Contributions of interleukin-5 and granulocyte/macrophage colony-stimulating factor.
    Adachi T; Motojima S; Hirata A; Fukuda T; Makino S
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):618-23. PubMed ID: 7881646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
    Solomon A; Shmilowich R; Shasha D; Frucht-Pery J; Pe'er J; Bonini S; Levi-Schaffer F
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1038-44. PubMed ID: 10752939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GM-CSF analogue E21R induces apoptosis of normal and activated eosinophils.
    Iversen PO; Robinson D; Ying S; Meng Q; Kay AB; Clark-Lewis I; Lopez AF
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1628-32. PubMed ID: 9372686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival.
    Hallsworth MP; Soh CP; Twort CH; Lee TH; Hirst SJ
    Am J Respir Cell Mol Biol; 1998 Dec; 19(6):910-9. PubMed ID: 9843925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of eosinophil chemotaxis by interleukin-5.
    Warringa RA; Schweizer RC; Maikoe T; Kuijper PH; Bruijnzeel PL; Koendermann L
    Am J Respir Cell Mol Biol; 1992 Dec; 7(6):631-6. PubMed ID: 1449809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.
    Owen WF; Rothenberg ME; Silberstein DS; Gasson JC; Stevens RL; Austen KF; Soberman RJ
    J Exp Med; 1987 Jul; 166(1):129-41. PubMed ID: 3110347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevations in granulocyte-macrophage colony-stimulating factor and interleukin-5 levels precede posttreatment eosinophilia in onchocerciasis.
    Hagan JB; Bartemes KR; Kita H; Ottesen EA; Awadzi K; Nutman TB; Gleich GJ
    J Infect Dis; 1996 May; 173(5):1277-80. PubMed ID: 8627086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.